AP01

Drug identity checked against registry records

Also recorded as Pirfenidone Solution

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)NCT06951217AVLNPhase 2Recruiting2031-12-31Estimated
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary FibrosisNCT06329401AVLNPhase 2Active not recruiting2027-06Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.